Angiotensin II induces hepatic steatosis and inflammation by increasing reactive oxygen species (ROS) following stimulation of type 1 angiotensin II receptors in animal NASH models [26,27]. The gene discussed is AGT; the disease is metabolic dysfunction-associated steatohepatitis.